The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete.
The reader should not assume that the information is accurate and complete.

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 13F

FORM 13F INFORMATION TABLE

OMB APPROVAL
OMB Number: 3235-0006
Estimated average burden
hours per response: 23.8

COLUMN 1 COLUMN 2 COLUMN 3 COLUMN 4 COLUMN 5 COLUMN 6 COLUMN 7 COLUMN 8
VALUE SHRS OR SH/ PUT/ INVESTMENT OTHER VOTING AUTHORITY
NAME OF ISSUER TITLE OF CLASS CUSIP (x$1000) PRN AMT PRN CALL DISCRETION MANAGER SOLE SHARED NONE
ABBVIE INC COM 00287Y109 1,618 15,000 SH   SOLE   15,000 0 0
ACCURAY INC COM 004397105 7,347 1,860,000 SH   SOLE   1,860,000 0 0
ALDEYRA THERAPEUTICS INC COM 01438T106 2,722 310,000 SH   SOLE   310,000 0 0
AMERISOURCEBERGEN CORP COM 03073E105 1,672 14,000 SH   SOLE   14,000 0 0
BRISTOL-MYERS SQUIBB CO COM 110122108 1,657 28,000 SH   SOLE   28,000 0 0
CARDINAL HEALTH INC COM 14149Y108 1,583 32,000 SH   SOLE   32,000 0 0
EVOLUS INC COM 30052C107 2,286 300,000 SH   SOLE   300,000 0 0
HARMONY BIOSCIENCES HLDGS IN COM 413197104 7,091 185,000 SH   SOLE   185,000 0 0
IRONWOOD PHARMACEUTICALS INC COM CL A 46333X108 8,946 685,000 SH   SOLE   685,000 0 0
LA JOLLA PHARMACEUTICAL CO COM PAR $.0001 2 503459604 1,077 270,000 SH   SOLE   270,000 0 0
LANNET INC COM 516012101 5,325 1,775,000 SH   SOLE   1,775,000 0 0
MCKESSON CORP COM 58155Q103 1,595 8,000 SH   SOLE   8,000 0 0
RIGEL PHARMACEUTICALS INC COM NEW 766559603 6,407 1,765,000 SH   SOLE   1,765,000 0 0
SUPERNUS PHARMACEUTICALS INC COM 868459108 8,934 335,000 SH   SOLE   335,000 0 0
UROGEN PHARMA LTD COM M96088105 1,262 75,000 SH   SOLE   75,000 0 0
UTAH MED PRODS INC COM 917488108 3,899 42,000 SH   SOLE   42,000 0 0
ZOGENIX INC COM NEW 98978L204 3,342 220,000 SH   SOLE   220,000 0 0